Exane BNP Paribas analyst Alistair Johnson initiates coverage on DraftKings (NASDAQ:DKNG) with a Underperform rating.
Why Cerevel Therapeutics Holdings Is Moving After-Hours
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading higher in Wednesday's after-hours session after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of